Clinical Trial Update: Trial of Low-Dose Xenon For The Treatment Of Obsessive-Compulsive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating low-dose xenon for obsessive-compulsive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Low-Dose Xenon (xenon)

Snippet

Sponsor: Mclean Hospital | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: WITHDRAWN